These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phototherapy for psoriasis. Hönigsmann H Clin Exp Dermatol; 2001 Jun; 26(4):343-50. PubMed ID: 11422187 [TBL] [Abstract][Full Text] [Related]
4. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Warren RB; Griffiths CE Clin Dermatol; 2008; 26(5):438-47. PubMed ID: 18755362 [TBL] [Abstract][Full Text] [Related]
5. Psoriasis in children: a guide to its diagnosis and management. Leman J; Burden D Paediatr Drugs; 2001; 3(9):673-80. PubMed ID: 11688598 [TBL] [Abstract][Full Text] [Related]
6. Psoriasis: current perspectives with an emphasis on treatment. Linden KG; Weinstein GD Am J Med; 1999 Dec; 107(6):595-605. PubMed ID: 10625029 [TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriasis. Part 2. Systemic therapies. Lebwohl M; Ali S J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913 [TBL] [Abstract][Full Text] [Related]
9. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis. Maryles S; Rozenblit M; Lebwohl M J Dermatolog Treat; 2003; 14 Suppl 2():7-16. PubMed ID: 14578093 [TBL] [Abstract][Full Text] [Related]
10. Systemic and light therapies for the management of childhood psoriasis: part II. Cordoro KM Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort. Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139 [TBL] [Abstract][Full Text] [Related]
12. [Prescription of phototherapy in psoriasis]. Beani JC Rev Prat; 2004 Jan; 54(1):43-7. PubMed ID: 15049599 [TBL] [Abstract][Full Text] [Related]
13. [Systemic therapy of psoriasis]. Altmeyer P; Nüchel C Dtsch Med Wochenschr; 1996 Dec; 121(51-52):1605-7. PubMed ID: 9011488 [No Abstract] [Full Text] [Related]
15. Psoriasis therapy: a current perspective. Lowe NJ West J Med; 1983 Aug; 139(2):184-9. PubMed ID: 6195826 [TBL] [Abstract][Full Text] [Related]
16. Treatment of moderate-to-severe plaque psoriasis. Salgo R; Thaçi D G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408 [TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it]. Stiefelhagen P MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277 [No Abstract] [Full Text] [Related]
18. Management of patients with psoriasis. Croney S Br J Nurs; 2017 Mar; 26(5):260-262. PubMed ID: 28328264 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic management of psoriasis]. Guilhou JJ Ann Dermatol Venereol; 1996; 123(4):276-9. PubMed ID: 8763756 [No Abstract] [Full Text] [Related]
20. Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence. Papp KA; Toth D; Rosoph L BMC Dermatol; 2006 Oct; 6():9. PubMed ID: 17067371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]